Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Change in Acquisitions & Divestments (2018 - 2025)

Historic Change in Acquisitions & Divestments for Abeona Therapeutics (ABEO) over the last 8 years, with Q2 2025 value amounting to $98.1 million.

  • Abeona Therapeutics' Change in Acquisitions & Divestments rose 47345.69% to $98.1 million in Q2 2025 from the same period last year, while for Sep 2025 it was $182.3 million, marking a year-over-year increase of 7332.01%. This contributed to the annual value of $120.2 million for FY2024, which is 13127.9% up from last year.
  • Abeona Therapeutics' Change in Acquisitions & Divestments amounted to $98.1 million in Q2 2025, which was up 47345.69% from $54.3 million recorded in Q1 2025.
  • Over the past 5 years, Abeona Therapeutics' Change in Acquisitions & Divestments peaked at $98.1 million during Q2 2025, and registered a low of $8.7 million during Q1 2022.
  • For the 5-year period, Abeona Therapeutics' Change in Acquisitions & Divestments averaged around $26.0 million, with its median value being $19.5 million (2021).
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first crashed by 6531.78% in 2022, then surged by 47345.69% in 2025.
  • Quarter analysis of 5 years shows Abeona Therapeutics' Change in Acquisitions & Divestments stood at $16.2 million in 2021, then plummeted by 44.99% to $8.9 million in 2022, then soared by 67.46% to $15.0 million in 2023, then skyrocketed by 100.22% to $30.0 million in 2024, then soared by 227.41% to $98.1 million in 2025.
  • Its Change in Acquisitions & Divestments was $98.1 million in Q2 2025, compared to $54.3 million in Q1 2025 and $30.0 million in Q4 2024.